Jens Juul Holst

Jens Juul Holst

Professor


  1. 2001
  2. Published

    Effect of calcitonin gene-related peptide (CGRP) on motility and on the release of substance P, neurokinin A, somatostatin and gastrin in the isolated perfused porcine antrum

    Rasmussen, T. N., Schmidt, P., Poulsen, S. S., Holst, Jens Juul & Poulsen, Steen Seier, 1 Aug 2001, In: Neurogastroenterology and Motility. 13, 4, p. 353-359 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Localisation and neural control of the release of calcitonin gene-related peptide (CGRP) from the isolated perfused porcine ileum

    Rasmussen, T. N., Schmidt, P., Poulsen, S. S., Holst, Jens Juul & Poulsen, Steen Seier, 20 Apr 2001, In: Regulatory Peptides. 98, 3, p. 137-143 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon

    Jeppesen, Palle Bekker, Hartmann, Bolette, Thulesen, J., Graff, J., Lohmann, J., Hansen, B. S., Tofteng, F., Poulsen, Steen Seier, Madsen, J. L., Holst, Jens Juul & Mortensen, P. B., Mar 2001, In: Gastroenterology. 120, 4, p. 806-815 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    No reactive hypoglycaemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose

    Vilsbøll, Tina, Krarup, T., Madsbad, Sten & Holst, Jens Juul, 1 Feb 2001, In: Diabetic Medicine. 18, 2, p. 144-149 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Additive glucose-lowering effects of glucagon-like peptide- 1 and metformin type 2 diabetes

    Zander, M., Taskiran, M., Toft-Nielsen, M. B. & Holst, Jens Juul, 2001, In: Diabetes Care. 24, p. 720-725

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Antidiabetogenic action of glucagon-like peptide- 1 related to administration relative to meal intake in subjects with type 2 diabetes

    Gutniak, M. K., Svartberg, J., Hellstrom, P. M. & Holst, Jens Juul, 2001, In: J Intern Med. 250, p. 81-87

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Assesment of hepatic insulin action in obese type 2 diabetic patients

    Staehr, P., Hother-Nielsen, O., Levin, K. & Holst, Jens Juul, 2001, In: Diabetes. 50, p. 1363-1370

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Attenuated processing of proglucagon and glucagon-like peptide- 1 in carboxypeptidase E-deficient mice

    Friis-Hansen, L., Lacourse, K. A., Samuelson, L. C. & Holst, Jens Juul, 2001, In: J. Endocrinol.. 169, p. 595-602

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Determinants of the effectiveness of glucagon-like peptide- 1 in type 2 diabetes

    Toft-Nielsen, M. B., Madsbad, S. & Holst, Jens Juul, 2001, In: J Clin Endocr Metab. 86, p. 3853-3860

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

    Toft-Nielsen, M. B., Damholt, M. B., Madsbad, Sten, Hilsted, L. M., Hughes, T. E., Michelsen, B. K. & Holst, Jens Juul, 2001, In: Journal of Clinical Endocrinology and Metabolism. 86, 8, p. 3717-3723 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 Next

ID: 4207